Ad
related to: sanofi- Careers
Join our Mission to Improve
the Lives of Patients.
- Approved Medicines
See the Approved Treatments
Using Our Antibody Science.
- Antibody Science
Explore Our Unique Platforms
For Creating Antibody Treatments.
- Sign Up
Sign Up for Updates, News
and Much More.
- Careers
Search results
Sarclisa Combination Improves Progression-Free Survival in Patients with Newly Diagnosed...
Pharmaceutical Executive Magazine· 3 days agoResults from the IMROZ Phase III trial show that Sanofi’s Sarclisa (isatuximab-irfc) in combination...
A salty diet may increase eczema in adults, study finds
Washington Post via Yahoo News· 1 day agoAdults who eat a salty diet appear to have a higher risk for eczema, according to a study by...
Novavax, With A 369% Gain, Tears Ahead Again On A Key FDA Move
Investor's Business Daily· 1 day agoIn a filing with the Securities and Exchange Commission, Novavax said the FDA said it completed its...
Growth Stocks to Avoid Like the Plague: 3 Overpriced Picks Primed to Plummet
InvestorPlace via Yahoo Finance· 6 days agoGrowth stocks can be millionaire-makers and the same ideas can be destroyers of wealth. The...
3 Dividend Stocks to Buy in June 2024 for Dependable Dividend Growth
InvestorPlace· 4 days agoInvesting in dividend growth stocks is a popular strategy for those seeking a dependable income...
Delaware judge lets more than 70,000 Zantac lawsuits go forward
Investing.com· 7 days ago“This moves us one step closer to justice for our clients,” Brent Wisner, one of the plaintiffs...
Zantac Heart Burn Continues For GSK As US Court Ruling Allows Thousands Of Zantac Lawsuits To Move...
Benzinga via Yahoo Finance· 4 days agoOn Monday, GSK Plc (NYSE:GSK) shares were down after the Delaware State Court ruled that more than...
Delaware judge lets more than 70,000 Zantac lawsuits go forward
Reuters· 6 days agoA Delaware judge has allowed more than 70,000 lawsuits over discontinued heartburn drug Zantac to go...
Anti-CD20 HGG Linked to Serious Infection Risk in MS
Medscape· 16 hours agoHypogammaglobulinemia is a known risk linked to B-cell–depleting therapies, but a real-world study has specified the risk and risk factors in multiple...
Delaware judge lets more than 70,000 Zantac lawsuits go forward
Colorado Springs Gazette· 6 days agoThe ruling on Friday by Judge Vivian Medinilla of the Delaware Superior Court in Wilmington is a...
